Al Qassimi Hospital in Sharjah, affiliated with the Emirates Health Services Corporation, announced that it has achieved an important achievement by implementing the “enVast” system, which is the latest global technology in the field of removing heart clots.
This development contributes to accelerating therapeutic intervention, which has a positive impact on saving patients’ lives and reducing serious complications resulting from clogged arteries.
Al Qassimi Hospital adopts Invast technology to treat heart attacks
This achievement reflects Al Qasimi Hospital’s ongoing commitment to adopting the latest medical innovations to improve the quality of specialized care provided.
Dr. Issam Al Zarouni, Executive Director of the Medical Services Sector at the Emirates Health Services Corporation, stated that the introduction of “Invast” technology translates the Corporation’s vision of raising the level of specialized services by enhancing the readiness of medical facilities to deal with critical cases in accordance with international standards.
Al Zarouni pointed out that investing in advanced therapeutic technologies represents a fundamental pillar of Al Qasimi Hospital’s strategy, which aims to develop a sustainable health care system that is in line with international best practices and contributes to improving health outcomes for patients.
Increasing the chances of recovery
Dr. Arif Al Nouryani, Executive Director and Head of the Heart Center at Al Qassimi Hospital in Sharjah, confirmed that adopting the “INVAST” technology reflects the Emirates Health Services Corporation’s commitment to providing the latest internationally approved therapeutic solutions in its facilities.
Al-Nouryani explained in statements to WAM that this measure enhances the speed of the medical response in critical moments, which increases the chances of recovery and improves the health outcomes of patients.
He also stressed the Emirates Health Services Corporation’s keenness to develop specialized care for cardiovascular diseases by adopting advanced medical technologies and attracting specialized competencies.
Al-Nouriani pointed out that these efforts ensure the provision of integrated health care that matches the best international standards, which contributes to saving patients’ lives and enhancing their quality of life.
The head of the Heart Center at Al Qasimi Hospital in Sharjah explained that this technology is considered one of the latest therapeutic methods in the field of dealing with acute heart attacks in the world.
Al-Nouriani added that this technology allows blood clots to be removed quickly and efficiently, which leads to the safe restoration of blood flow, thus saving patients’ lives and reducing serious complications.
The head of the Heart Center at Al Qasimi Hospital in Sharjah confirmed that this technology was used successfully with a number of patients during a critical period of time that did not exceed 24 hours from the appearance of symptoms, in accordance with the latest approved medical protocols.
He said that this medical device has the European Conformity Mark (CE) in addition to the approval of the US Food and Drug Administration (FDA), which reflects the safety and efficiency of the high technology, and enhances its reliability as an advanced therapeutic option in the management of acute heart attacks.
Severe heart attacks
The report indicated that the patients who underwent treatment using the “Invast” technology ranged in age from 41 to 55 years, and were suffering from severe heart attacks accompanied by multiple risk factors, such as diabetes, high blood pressure, high cholesterol, and smoking.
The statement explained that the rapid intervention using this technique contributed to the restoration of normal blood flow after the completion of the operation by 98% and the stabilization of the health condition.
